Status:
UNKNOWN
Decreasing Dialysis Cardiovascular Risk: Daily Versus Longer Treatments
Lead Sponsor:
Dallas VA Medical Center
Conditions:
Cardiovascular Disease
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Given the known increased risk of heart disease in hemodialysis patients, this study aims to evaluate the change in both size and function of the heart by using cardiac magnetic resonance imaging (MRI...
Eligibility Criteria
Inclusion
- End stage renal disease patients on hemodialysis
Exclusion
- Weight \> 350 lbs
- Known poor dialysis and or treatment compliance
- Unable to come for daily treatments if randomization occurs in this group
- Prognosis less than 6 months
- Difficulty in tolerating dialysis and possibility of discontinuation of dialysis before 6 months
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00925483
Start Date
August 1 2004
Last Update
February 25 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dallas VA Medical Center
Dallas, Texas, United States, 75216